Diabetes and Covid-19: An interplay difficult to dissect

Affiliations

Comment

Raffaele Napoli. Diabetes Metab Res Rev. 2021 Jan.

. 2021 Jan;37(1):e3387.

doi: 10.1002/dmrr.3387. Epub 2020 Aug 20.

¹ Department of Translational Medical Sciences, Federico II University School of Medicine, Naples, Italy.

No abstract available

Keywords: Covid-19; cardiovascular diseases; diabetes mellitus.

Conflict of interest statement

The author declares no conflicts of interests related to this manuscript.

Diabetes is a risk factor for the progression and prognosis of COVID-19.
Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, Qin R, Wang H, Shen Y, Du K, Zhao L, Fan H, Luo S, Hu D. Guo W, et al. Diabetes Metab Res Rev. 2020 Oct;36(7):e3319. doi: 10.1002/dmrr.3319. Epub 2020 Apr 7. Diabetes Metab Res Rev. 2020. PMID: 32233013 Free PMC article.

1. Guo W, Li M, Dong Y, et al. Diabetes is a risk factor for the progression and prognosis of COVID‐19. Diabetes Metab Res Rev. 2020;e3319. 10.1002/dmrr.3319. - DOI - PMC - PubMed
1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID‐19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054‐1062. - PMC - PubMed
1. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus‐infected pneumonia in Wuhan, China. JAMA. 2020;323:1061. - PMC - PubMed
1. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180:934. 10.1001/jamainternmed.2020.0994. - DOI - PMC - PubMed
1. Onder G, Rezza G, Brusaferro S. Case‐fatality rate and characteristics of patients dying in relation to COVID‐19 in Italy. JAMA. 2020;323:1775‐1776. 10.1001/jama.2020.4683. - DOI - PubMed